Rocket Pharmaceuticals officer proposes $6.8K sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ROCKET PHARMACEUTICALS, INC. officer and director Gaurav Shah gave notice of a proposed sale of 3,020 common shares, with an aggregate market value of $6,795.91 and an approximate sale date of November 13, 2026. The shares were acquired from the issuer through restricted stock vesting on November 11, 2026, as compensation. The notice says the proposed sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution. It also lists Shah’s sales during the preceding three months: 2,837 shares on August 13, 2026, and 2,293 shares on August 18, 2026.
Key Figures
Key Terms
Restricted Stock Vesting financial
Vested equity award distribution financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why does Gaurav Shah’s RCKT sale notice mention taxes?
AI-generated analysis. How Rhea-AI works. Not financial advice.